Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1381 to 1395 of 2184 results for guidelines

  1. What is the effectiveness and safety of extended pharmacological venous thromboembolism (VTE) prophylaxis for people who have been discharged after treatment for COVID-19?

    Source guidance details Comes from guidance COVID-19 rapid guideline: managing COVID-19 Number NG191 Date issued March

  2. Omalizumab for previously treated chronic spontaneous urticaria (TA339)

    Evidence-based recommendations on omalizumab (Xolair) for treating severe chronic spontaneous urticaria in people of 12 and over.

  3. Expectant management before IVF:- What is the optimum period of expectant management for women of different age groups before invasive treatment such as IVF is considered?

    with advancing age because of a woman's decreasing ovarian reserve. The guideline currently recommends a shorter period of expectant...

  4. Apart from culture, what other diagnostic tests or combinations of tests are effective inestablishing an accurate diagnosis of active respiratory TB in children and young people withsuspected active TB?

    Any explanatory notes(if applicable) Why this is important The guideline committee noted the lack of evidence on the diagnosis of active...

  5. Effectiveness of web-based parenting programmes:- Are web-based parenting programmes effective and cost effective for improving parenting and preventing recurrence of child abuse and neglect in families where child abuse or neglect has occurred?

    families where child abuse or neglect has occurred. Our review for this guideline identified 1 small-scale US study of a web-based...

  6. What is the effectiveness and safety of neutralising monoclonal antibodies against different SARS-CoV-2 variants?

    Source guidance details Comes from guidance COVID-19 rapid guideline: managing COVID-19 Number NG191 Date issued March

  7. Adding a newer anti-anginal drug to a calcium channel blocker:- What is the clinical and cost effectiveness of adding a newer anti-anginal drug (nicorandil, ivabradine or ranolazine) to a calcium channel blocker for treating stable angina?

    clinical practice and inform future updates of key recommendations in this guideline. Source guidance details Comes from guidance Stable...

  8. Safety and safeguarding:- What safeguarding practices are most effective in improving outcomes for people using services?

    Any explanatory notes(if applicable) Why it is important:- The Guideline Committee identified variation in organisational attitudes to,...

  9. Information and support:- What information and support interventions are effective to help women with endometriosis deal with their symptoms and improve their quality of lives?

    Any explanatory notes(if applicable) Why this is important:- This guideline has identified that women with endometriosis and their...

  10. Pulmonary artery pressure technologies for remote monitoring of chronic heart failure (HTG769)

    Evidence-based recommendation on the routine use of pulmonary artery pressure technologies for remote monitoring of chronic heart failure.

  11. Evidence summaries: new medicines – Interim process statement (PMG1)

    This interim process statement sets out to guide the development of 'Evidence summaries: new medicines' (ESNMs). It provides an overview of the key process principles and describes all stages of the development of ESNMs

  12. In people with suspected COVID-19-associated pulmonary aspergillosis (CAPA), what are the most accurate tests for diagnosing the infection and when should they be done?

    Source guidance details Comes from guidance COVID-19 rapid guideline: managing COVID-19 Number NG191 Date issued March